Albert Gründer Selected Research

NF-E2 Transcription Factor

1/2020	The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.
1/2012	A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Gründer Research Topics

Disease

4	Neoplasms (Cancer) 05/2021 - 01/2016
2	Polycythemia (Erythrocytosis) 01/2016 - 05/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Reticulocytosis 01/2016
1	Thrombocytosis (Thrombocythemia) 05/2013
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2012

Drug/Important Bio-Agent (IBA)

2	NF-E2 Transcription FactorIBA 01/2020 - 01/2012
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2016
1	ruxolitinibIBA 05/2021
1	Insulin (Novolin)FDA Link 05/2021
1	antineoplaston A10 (A 10)IBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	GlobinsIBA 01/2016
1	IronIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 05/2013